TELA Bio, Inc. - Common stock — Cash Flow (NASDAQ:TELA) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -24.46 M-30.43 M-40.75 M-40.86 M-41.59 M-28.22 M -29.66 M Cash from investing activities 9.12 M-627 K-1.87 M-599 K4.45 M846 K 898 K Cash from financing activities 44.41 M585 K40.85 M46.27 M43.06 M25.75 M 25.57 M Free cash flow -24.46 M-30.43 M-40.75 M-40.86 M-41.59 M-28.67 M -30.2 M

News

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio Analysts Cut Their Forecasts After Q4 Results - TELA Bio (NASDAQ:TELA)

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Becton Dickinson (NYSE:BDX), TELA Bio (NASDAQ:TELA)

TELA Bio stock price target lowered to $3 by Lake Street on sales issues

Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results